Dr Nicola Dallas

Berkshire Oncology Partnership

Clinical oncology

  • Fee assured

This healthcare professional let us know that they are currently:

  • Accepting new patients
  • Available for:
    • Face-to-face consultations
    • Phone consultations

Last updated: 15 Apr 2020

Specialises in

  • Urology


  • Home chemotherapy

About us

Dr Dallas is a Consultant Clinical Oncologist for NHS patients at the Royal Berkshire Hospital in Reading and Wexham Park Hospital in Slough and has been a partner in the Berkshire Oncology Partnership since 2012.
Dr Dallas graduated from the University of Birmingham Medical School in 1998 and became a member of the Royal College of Physicians in 2001. She completed her specialist oncology training in Oxford becoming a Fellow of the Royal College of Radiologists in 2007. She was appointed as a Consultant Clinical Oncologist at the Berkshire Cancer Centre, Royal Berkshire Hospital in Reading in 2011.
Dr Dallas specialises in the treatment of prostate, bladder, kidney and testicular cancers, head and neck and thyroid cancers. She has a particular interest in technical radiotherapy techniques including IMRT, dynamic arc IMRT and IGRT.
She is the principle investigator for a number of phase 3 clinical trials in urological and head and neck cancers.
At the Berkshire Cancer Centre she is the Clinical Governance and Audit Lead as well as an educational and clinical supervisor to specialist oncology trainees.

Areas of interest

Urology; prostate cancer; bladder cancer;kidney cancer; renal cancer; testicular cancer; germ cell tumours; head & neck cancer; oropharyngeal cancer, tonsil cancer; tongue cancer; nasopharyngeal cancer; salivary gland tumours; thyroid cancer; radiotherapy; IMRT; IGRT; Stereotactic radiotherapy; SABR; SBRT; MR Linac, Hormone therapy; chemotherapy; immunotherapy; biological therapies; therapeutic radioisotopes

Medical secretaries

Our qualifications & training
Our private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0004

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)

    GenesisCare, Windsor (5-50)

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)

    GenesisCare, Windsor (1-5)

  • X6581

    Clinical supervision of the delivery of a single fraction of radiotherapy - (5-50)

    GenesisCare, Windsor (5-50)

  • X6774

    Preparation for intermediate radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (5-50)

    GenesisCare, Windsor (5-50)

  • X0008

    Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (5-50)

    GenesisCare, Windsor (5-50) Spire Dunedin Hospital (1-5)

  • X0007

    Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (5-50)

    GenesisCare, Windsor (5-50) GenesisCare, Oxford (1-5)

  • X6772

    Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)

    Spire Dunedin Hospital (1-5) GenesisCare, Windsor (1-5)

  • A1070

    Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)

    GenesisCare, Oxford (1-5)

  • X6930

    Clinical supervision of the planning of a course of complex radiotherapy - (1-5)

    GenesisCare, Windsor (1-5)

  • Show All (13)...
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.